Our Mission, Vision & Values

Our Mission

To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide.

Our Vision

Lead the way to a healthier world.

Our Values

  • Serve and create value for patients
  • Act with the highest standards
  • Trust and empower our people
  • Align, collaborate and win as one team

The goal of Sunovion Pharmaceuticals Europe is to build a successful European business which will commercialise innovative treatment options focusing on patients suffering from psychiatric, neurological, and other conditions. The team plans to do this by creating an efficient and sustainable European organisation that develops effective relationships with a network of the best suppliers and business partners. We strive to continually develop our people and collaborate effectively with colleagues in our global team.

Sunovion Pharmaceuticals Europe has designed and successfully executed a relatively unique “Hub & Spoke” business model which is now operating smoothly across seven countries, and will continue to expand as the company grows. We have a strong commitment to our London location as our European office (or "Hub") for this business model.

The company plans to develop and commercialise a portfolio of products across Europe building on the lurasidone platform. The portfolio of products will be realised via a dual strategy of late-stage pipeline development of Sunovion assets and an aggressive in-licencing/acquisition programme.

Empowering the global healthcare community

We believe we have a vital role in providing needed support and fostering wellness for those dealing with serious medical conditions. This belief anchors all that we do and sharpens our singular focus on the people we help, not just the medical conditions they deal with—from the development of therapies that positively impact the lives of millions worldwide, to our advocacy involvement to generate a deeper understanding of these disorders. Patients are at the centre of everything we do.

Developing a robust pipeline of potential new therapies

Sunovion's spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the centre of everything it does, Sunovion has charted new paths to target life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions.

Delivering important therapies for serious medical conditions

Sunovion’s track record of discovery, development and commercialisation of important therapies includes lurasidone for the treatment of schizophrenia in adults.

Acting with compassion and responsibility

Sunovion has a commitment to work with partners to support the local, regional and global community as part of our overall Corporate Social Responsibility efforts. Collaboration helps in meaningful ways to build stronger communities where our employees live and work, a passion shared by our people.